Plasma lipidomic analysis of stable and unstable coronary artery disease. - Wikidata - awgldk - TriplyDB

Plasma lipidomic analysis of stable and unstable coronary artery disease.

Plasma lipidomic analysis of stable and unstable coronary artery disease.

http://www.wikidata.org/entity/Q39709364

about

Utility of mass spectrometry for the diagnosis of the unstable coronary plaque Novel methodologies for biomarker discovery in atherosclerosis Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a novel nucleotide phosphodiesterase regulated by cholesterol in human macrophages Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.Lipidomic analyses in epidemiology.Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.Alterations of plasma lysophosphatidylcholine species in obesity and weight loss.Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein.cAMP response element binding protein1 is essential for activation of steroyl co-enzyme a desaturase 1 (Scd1) in mouse lung type II epithelial cells.Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death Plasma lipid composition and risk of developing cardiovascular disease.Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes.Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction.An Efficient Single Phase Method for the Extraction of Plasma Lipids.Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia.Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice.Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts A comprehensive lipidomic screen of pancreatic β-cells using mass spectroscopy defines novel features of glucose-stimulated turnover of neutral lipids, sphingolipids and plasmalogens Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.Plasma lipid profiling in a large population-based cohort Shotgun Lipidomics by Sequential Precursor Ion Fragmentation on a Hybrid Quadrupole Time-of-Flight Mass Spectrometer Plasma dihydroceramide species associate with waist circumference in Mexican American families.Clinical and dietary predictors of common carotid artery intima media thickness in a population with type 1 and type 2 diabetes: A cross-sectional study.Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites.Quantitation of isobaric phosphatidylcholine species in human plasma using a hybrid quadrupole linear ion-trap mass spectrometer.Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus The emerging role of plasma lipidomics in cardiovascular drug discovery.Metabolomics and ischaemic heart disease.Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease.Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice.Lipidomics in vascular health: current perspectives.Better Indigenous Risk stratification for Cardiac Health study (BIRCH) protocol: rationale and design of a cross-sectional and prospective cohort study to identify novel cardiovascular risk indicators in Aboriginal Australian and Torres Strait Islan Identifying new Risk Markers and Potential Targets for Coronary Artery Disease: The Value of the Lipidome and Metabolome.Alteration in Phospholipidome Profile of Myoblast H9c2 Cell Line in a Model of Myocardium Starvation and Ischemia.

P2860

Q26780282-FA2BC71A-C11A-42B7-9E07-8E7C8EBF7C8F Q28088373-D6C335D7-FC01-460C-A9A5-A6983E5B6EEE Q28118272-5BEB2DE4-2CE1-4F39-8F95-FA841C3D1E08 Q28395402-6FB1044F-7CA6-4CD3-8B83-EF7E3517C5B5 Q28611371-2BCE7E0F-60E2-46BF-8926-CE180CFA9CA9 Q30241943-5BA23B0A-92CD-414F-B045-9E23001D3645 Q30249688-F4B35E46-1E20-40A7-868D-919890EAA932 Q34358476-E2C595B6-CFCF-4125-AFBF-5852C3084A2D Q34395775-249FD34C-EC14-4171-AE69-491A58FF5AAB Q34599077-7B3D59A7-721B-42C4-A802-F65C1CFF1CE5 Q34699881-4F4C8C28-5EEE-40E8-8BE9-8C98F22BA948 Q34734762-6FA24CE6-B1F8-4ADF-93B3-822191988E4F Q34964585-0B8981C2-6304-45E0-86C1-5E81C5D0130B Q35004985-F426C58C-880D-4E54-9216-FFA6E195AB3A Q35014728-2427CB0D-61DE-40F8-A6CB-B8C20B3CD639 Q35148082-65FE8935-8477-44BD-9CD2-9534C2138903 Q35741256-80F4745D-A84A-44FC-9B43-68C33CFCA2EE Q35829914-30DA138E-1952-47F9-A36E-9AD5352AD686 Q36018490-59A51DC9-C481-4B01-8309-39244927E69C Q36307308-BC42435A-5192-4DD9-BABD-E3862C7674EE Q36410748-83A2DFBA-2312-4586-8512-E74F21B526E8 Q36765489-5670F34C-5DD9-45AF-B587-D06086085C04 Q36928728-EED4A549-C753-41F0-A129-4CAEB6216BC4 Q37057113-886A75B6-99B6-467D-BB54-2C6964EBEF4F Q37163090-DA70B63B-4D91-4373-9303-15A05079FBE9 Q37512573-E41B2177-00AE-4D08-9F1C-B95873EF08AD Q37569388-F48A58B2-A7D0-4359-8148-5FC936FEA049 Q37587463-150276D7-F402-49A9-9363-B7FC627628FE Q37592818-14969618-3E2A-465C-B1C2-CFDB9714FF18 Q37604483-4A9A2BDE-7CFE-4106-A4EE-B7899E267A78 Q37659362-01E9E251-46D2-4A9F-87E6-7B5A511543EA Q37700127-6C40E645-66A0-49C8-8A80-E38AE28C1A16 Q37999089-92A3B14E-A4B8-4414-B926-DD132E067643 Q38060209-0CC678B1-8A4F-477C-951A-03B73513D58A Q38252517-3BCBDC62-FDA5-49AE-B8C4-E35E6AC42180 Q38324690-2DD20844-BAB1-48D3-9059-C944E16EF92B Q38537535-749CFAE2-EC20-4030-8D4B-E521DA046544 Q38611359-A1E51B15-779C-4D2B-936C-87BC5C51B478 Q38741609-2EB0D7CB-0A4D-4D86-9963-B8CD1D249450 Q38793384-A7553737-B38C-4F8D-AD9B-DA8954314DE4

P2860

Plasma lipidomic analysis of stable and unstable coronary artery disease.

http://www.wikidata.org/entity/Q39709364

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@en

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@nl

type

label

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@en

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@nl

prefLabel

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@en

Plasma lipidomic analysis of stable and unstable coronary artery disease.

@nl

P1433

Q39709364-A3216DDF-62B6-42D1-A19D-03F9F8B27769

P1476

Q39709364-33C87EA6-D849-4344-A92E-C965FBB1B7B5

P2093

Q39709364-4C9AF8BB-0810-49BA-9D03-19D1BF9A2799

Q39709364-644D05BF-69E8-44BF-8B4E-8F1D614CE269

Q39709364-8222A248-3141-4778-BDD6-E6A29A870B48

Q39709364-9D6626BA-D4BC-428B-AA4B-121E703B7881

Q39709364-BB9E4574-879A-478F-BACA-2274000D8403

Q39709364-C8210280-2657-493A-93CD-8E13FD3CFA54

Q39709364-CC4A0475-CF79-4117-A1D8-62F5378718E8

Q39709364-DD330E2F-F537-47E2-9AA8-FBAC3DE01329

Q39709364-F68E7B80-8E75-4391-A677-79801601313F

P304

Q39709364-C4A35722-FDC7-4771-93B1-16EC58238B23

P31

Q39709364-AB6EB2C4-D66A-4AFA-9BB9-5DC3BE0BD460

P356

Q39709364-04FE3397-E39E-4642-ADA7-498D9113642E

P407

Q39709364-E008D4D4-A867-49B6-B6D3-A5375C46F37C

P433

Q39709364-20E234B1-4A29-4CF8-9241-75D4BAB98EB3

P478

Q39709364-8B06B87C-A88E-4426-8A2F-F7590D6B61ED

P50

Q39709364-00042D9D-25AE-4C14-82D5-D6F139BD9576

Q39709364-05EDD0A8-7E29-41C9-A9E3-0A6A3D93DE0C

Q39709364-27BADDB0-A22F-4A0B-81A3-19E53AD63ABC

Q39709364-2BBF4BFE-9B5D-4572-B6B0-1E6D6790EF93

Q39709364-4FD83E26-2BCD-43D0-A43E-53DD9E95DD76

Q39709364-D846AFF7-3ECB-49E6-ADF3-DA106D04430A

Q39709364-DB31E519-1F79-473E-9ACF-A6D007D3B959

P577

Q39709364-CF7BAA0A-A98B-4C25-8822-527591C3E76A

P698

Q39709364-4B24C6AF-E63B-497D-8569-F3A789E351FE

P356

ATVBAHA.111.234096

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Plasma lipidomic analysis of stable and unstable coronary artery disease

@en

P2093

Adam Kowalczyk

http://www.w3.org/2001/XMLSchema#string

Bronwyn A Kingwell

http://www.w3.org/2001/XMLSchema#string

Despina Tsorotes

http://www.w3.org/2001/XMLSchema#string

Gemma L MacIntosh

http://www.w3.org/2001/XMLSchema#string

Gerard Wong

http://www.w3.org/2001/XMLSchema#string

Izhak Haviv

http://www.w3.org/2001/XMLSchema#string

Jacquelyn M Weir

http://www.w3.org/2001/XMLSchema#string

Michael J Christopher

http://www.w3.org/2001/XMLSchema#string

Stephen J Duffy

http://www.w3.org/2001/XMLSchema#string

P304

2723-2732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.111.234096

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Garry L Jennings

Christopher K Barlow

Benjamin Goudey

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21903946

http://www.w3.org/2001/XMLSchema#string